$MED
MEDIFAST INC

2013 Q4 Form 10-K Financial Statement

#000114420414016118 Filed on March 17, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2012 Q4 2012
Revenue $70.30M $83.20M $356.7M
YoY Change -15.5% 19.54% 19.62%
Cost Of Revenue $18.30M $20.40M $82.66M
YoY Change -10.29% 18.6% 12.16%
Gross Profit $51.90M $62.80M $235.9M
YoY Change -17.36% 20.08% 5.08%
Gross Profit Margin 73.83% 75.48% 66.14%
Selling, General & Admin $41.90M $59.00M $208.8M
YoY Change -28.98% 16.37% 5.91%
% of Gross Profit 80.73% 93.95% 88.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $200.0K $8.385M
YoY Change -100.0% -92.0% 0.49%
% of Gross Profit 0.0% 0.32% 3.55%
Operating Expenses $41.90M $59.20M $208.8M
YoY Change -29.22% 16.77% 5.91%
Operating Profit $10.00M $3.600M $27.14M
YoY Change 177.78% 125.0% -0.88%
Interest Expense $200.0K $100.0K $304.0K
YoY Change 100.0% -200.0% -4.7%
% of Operating Profit 2.0% 2.78% 1.12%
Other Income/Expense, Net -$500.0K $0.00 $1.216M
YoY Change -100.0% 308.05%
Pretax Income $9.800M $3.600M $28.36M
YoY Change 172.22% 140.0% 2.44%
Income Tax $2.600M $1.800M $9.914M
% Of Pretax Income 26.53% 50.0% 34.96%
Net Earnings $5.300M $1.900M $15.88M
YoY Change 178.95% 58.33% -14.37%
Net Earnings / Revenue 7.54% 2.28% 4.45%
Basic Earnings Per Share $1.16
Diluted Earnings Per Share $389.7K $137.7K $1.16
COMMON SHARES
Basic Shares Outstanding 13.88M shares 13.72M shares
Diluted Shares Outstanding 13.74M shares

Balance Sheet

Concept 2013 Q4 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.2M $99.93M $60.00M
YoY Change 4.26% 195.65% 77.51%
Cash & Equivalents $36.38M $39.94M $39.90M
Short-Term Investments $67.80M $59.99M $20.10M
Other Short-Term Assets $5.600M $4.800M $4.800M
YoY Change 16.67% 41.18% 41.18%
Inventory $17.54M $20.80M $20.80M
Prepaid Expenses
Receivables $942.0K $2.148M $2.100M
Other Receivables $0.00 $900.0K $900.0K
Total Short-Term Assets $91.95M $88.58M $88.60M
YoY Change 3.81% 38.43% 38.44%
LONG-TERM ASSETS
Property, Plant & Equipment $34.48M $40.11M $40.10M
YoY Change -14.04% 3.24% 3.08%
Goodwill
YoY Change
Intangibles $0.00 $428.0K
YoY Change -100.0% -57.33%
Long-Term Investments
YoY Change
Other Assets $231.0K $1.139M $1.100M
YoY Change -79.72% -37.55% -38.89%
Total Long-Term Assets $40.70M $41.68M $41.70M
YoY Change -2.35% -0.01% 0.0%
TOTAL ASSETS
Total Short-Term Assets $91.95M $88.58M $88.60M
Total Long-Term Assets $40.70M $41.68M $41.70M
Total Assets $132.7M $130.3M $130.3M
YoY Change 1.84% 23.27% 23.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.00M $28.20M $28.20M
YoY Change -57.45% 50.0% 122.05%
Accrued Expenses $4.800M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $225.0K $500.0K
YoY Change -100.0% -83.93% -64.29%
Total Short-Term Liabilities $27.10M $28.75M $28.70M
YoY Change -5.73% 41.93% 41.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $3.113M $3.800M
YoY Change -100.0% -6.71% -11.63%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $3.113M $3.800M
YoY Change -100.0% -6.71% -11.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.10M $28.75M $28.70M
Total Long-Term Liabilities $0.00 $3.113M $3.800M
Total Liabilities $34.23M $39.47M $39.50M
YoY Change -13.25% 22.32% 22.29%
SHAREHOLDERS EQUITY
Retained Earnings $97.70M $76.53M
YoY Change 27.66% 26.17%
Common Stock $13.00K $16.00K
YoY Change -18.75% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $26.51M
YoY Change -100.0% 11.64%
Treasury Stock Shares 0.000 shares 1.609M shares
Shareholders Equity $98.42M $90.79M $90.80M
YoY Change
Total Liabilities & Shareholders Equity $132.7M $130.3M $130.3M
YoY Change 1.84% 23.27% 23.27%

Cashflow Statement

Concept 2013 Q4 2012 Q4 2012
OPERATING ACTIVITIES
Net Income $5.300M $1.900M $15.88M
YoY Change 178.95% 58.33% -14.37%
Depreciation, Depletion And Amortization $0.00 $200.0K $8.385M
YoY Change -100.0% -92.0% 0.49%
Cash From Operating Activities $8.300M $600.0K $40.26M
YoY Change 1283.33% -60.0% 15.47%
INVESTING ACTIVITIES
Capital Expenditures -$2.800M -$700.0K $8.127M
YoY Change 300.0% -84.78% -43.06%
Acquisitions
YoY Change
Other Investing Activities $3.000M -$3.800M -$3.500M
YoY Change -178.95% 375.0% 59.09%
Cash From Investing Activities $200.0K -$4.600M -$11.66M
YoY Change -104.35% -14.81% -30.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.764M
YoY Change -86.44%
Debt Paid & Issued, Net $1.444M
YoY Change 27.11%
Cash From Financing Activities -20.10M 600.0K -$2.925M
YoY Change -3450.0% -300.0% -86.0%
NET CHANGE
Cash From Operating Activities 8.300M 600.0K $40.26M
Cash From Investing Activities 200.0K -4.600M -$11.66M
Cash From Financing Activities -20.10M 600.0K -$2.925M
Net Change In Cash -11.60M -3.400M $25.68M
YoY Change 241.18% -19.05% -984.43%
FREE CASH FLOW
Cash From Operating Activities $8.300M $600.0K $40.26M
Capital Expenditures -$2.800M -$700.0K $8.127M
Free Cash Flow $11.10M $1.300M $32.14M
YoY Change 753.85% -78.69% 56.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
MED
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13115642 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
MEDIFAST INC
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000910329
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
342000000 USD
CY2013 us-gaap Revenues
Revenues
356886000 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
89040000 USD
CY2013 med Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization
SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization
222874000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11382000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
597000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34187000 USD
CY2013Q4 us-gaap Assets
Assets
132650000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
24458000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27680000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
614000 USD
CY2012 us-gaap Cost Of Revenue
CostOfRevenue
88671000 USD
CY2012 us-gaap Revenues
Revenues
356706000 USD
CY2012 med Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization
SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization
233568000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11205000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1196000 USD
CY2012Q4 us-gaap Assets
Assets
130251000 USD
CY2011 med Selling General And Administrative Expenses Excluding Depreciation Depletion And Amortization
SellingGeneralAndAdministrativeExpensesExcludingDepreciationDepletionAndAmortization
188770000 USD
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8344000 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
298000 USD
CY2011Q4 us-gaap Assets
Assets
105665000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
73402000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
90786000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
98416000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2524000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36382000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39937000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1246000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2148000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2850000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3209000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
18059000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
20804000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
31420000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
20057000 USD
CY2013Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0 USD
CY2012Q4 us-gaap Prepaid Taxes
PrepaidTaxes
873000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2890000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3296000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1957000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1460000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1265000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
383000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
91954000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
88575000 USD
CY2013 us-gaap Gross Profit
GrossProfit
267846000 USD
CY2012 us-gaap Gross Profit
GrossProfit
268035000 USD
CY2011 us-gaap Gross Profit
GrossProfit
224496000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40336000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40109000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
234256000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
244773000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
197114000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
428000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
33590000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
23262000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
27382000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
150000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
360000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1139000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9139000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27101000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28749000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.74
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.73
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.31
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13774083 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13721997 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13965018 shares
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6907000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
34234000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
39465000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
26508000 USD
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
506000 USD
CY2012 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
301000 USD
CY2011 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
319000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
23969000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
15876000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
18541000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
26780000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
28221000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000 USD
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
99000 USD
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
222000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
528000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10218000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8582000 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13817693 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13739824 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14198495 shares
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2011 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20389000 USD
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2764000 USD
CY2013 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20081000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3113000 USD
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
474000 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
696000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6659000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
703000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
97700000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130251000 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
257000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
269000 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
143000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
107000 USD
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
112000 USD
CY2011 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-13000 USD
CY2013 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
150000 USD
CY2012 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
157000 USD
CY2011 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
156000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24119000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16033000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18697000 USD
CY2013Q4 med Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
647000 USD
CY2013 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
74000 USD
CY2012 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2000 USD
CY2011 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-207000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
3209000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2850000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
2524000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-888000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1337000 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6015000 USD
CY2012Q4 med Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
542000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-425000 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-117000 USD
CY2011 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-902000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
671000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
854000 USD
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2745000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
835000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
435000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-406000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1045000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
143000 USD
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-753000 USD
CY2011 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
387000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22602000 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-150000 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
971000 USD
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1441000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9391000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3810000 USD
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
972000 USD
CY2012 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4561000 USD
CY2011 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2168000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42360000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40264000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34870000 USD
CY2013 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
14359000 USD
CY2012 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8109000 USD
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8064000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25355000 USD
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8390000 USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10278000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11606000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11383000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14273000 USD
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11664000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16874000 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3641000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1444000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1136000 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
26000 USD
CY2012 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
18000 USD
CY2011 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
12000 USD
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
383000 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1265000 USD
CY2011 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
614000 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3338000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20081000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
225000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2764000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20389000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23313000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2925000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20899000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3555000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25675000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2903000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11356000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13857000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
290000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
352000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14262000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17165000 USD
CY2013 us-gaap Interest Paid
InterestPaid
57000 USD
CY2012 us-gaap Interest Paid
InterestPaid
123000 USD
CY2011 us-gaap Interest Paid
InterestPaid
96000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
9983000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
4093000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
4125000 USD
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
104000 USD
CY2011 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1014000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5381000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5685000 USD
CY2013Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
757000 USD
CY2012Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
653000 USD
CY2013Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
855000 USD
CY2012Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
961000 USD
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13143309 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13115642 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15525955 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13767380 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1608908 shares
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
12000 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
62000 USD
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
89000 USD
CY2013 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2014-06-02
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
78191000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71674000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37855000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31565000 USD
CY2013 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
10954000 USD
CY2012 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
10116000 USD
CY2011 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7024000 USD
CY2013 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
912000 USD
CY2013 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
297000 shares
CY2013 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2672000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
66514000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2672000 USD
CY2012 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2672000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2244000 USD
CY2013Q4 us-gaap Interest Receivable
InterestReceivable
109000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
67802000 USD
CY2013Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
31420000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
1442000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
-263000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
428000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
572000 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
456000 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
58997000 USD
CY2012Q4 us-gaap Interest Receivable
InterestReceivable
111000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
59994000 USD
CY2012Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
20057000 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
942000 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
-56000 USD
CY2012Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3300000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14619000 USD
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
16226000 USD
CY2013Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5535000 USD
CY2012Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5549000 USD
CY2013Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1335000 USD
CY2012Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
3295000 USD
CY2013Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
3930000 USD
CY2012Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
3151000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26780000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
28221000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11106000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9919000 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3124000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
332000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
336000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
242000 USD
CY2013Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
0 USD
CY2012Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
0 USD
CY2011Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
301000 USD
CY2013Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
413000 USD
CY2012Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
692000 USD
CY2011Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
545000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
896000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
337000 USD
CY2012Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
526000 USD
CY2011Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
555000 USD
CY2013Q4 med Deferred Tax Assets Sales Tax Accrual
DeferredTaxAssetsSalesTaxAccrual
337000 USD
CY2012Q4 med Deferred Tax Assets Sales Tax Accrual
DeferredTaxAssetsSalesTaxAccrual
1228000 USD
CY2011Q4 med Deferred Tax Assets Sales Tax Accrual
DeferredTaxAssetsSalesTaxAccrual
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3575000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3472000 USD
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2159000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
-476000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
-333000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
-250000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
-710000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
-752000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
-426000 USD
CY2013Q4 med Deferred Tax Liabilities Depreciations
DeferredTaxLiabilitiesDepreciations
-7091000 USD
CY2012Q4 med Deferred Tax Liabilities Depreciations
DeferredTaxLiabilitiesDepreciations
-7729000 USD
CY2011Q4 med Deferred Tax Liabilities Depreciations
DeferredTaxLiabilitiesDepreciations
-8075000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
6663000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
5371000 USD
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3753000 USD
CY2013 us-gaap Equipment Expense
EquipmentExpense
1524000 USD
CY2013Q4 med Deferred Tax Liability Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilityTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2012Q4 med Deferred Tax Liability Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilityTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
-105000 USD
CY2011Q4 med Deferred Tax Liability Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilityTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
-109000 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-8277000 USD
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-8919000 USD
CY2011Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-8860000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
-4702000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
-5447000 USD
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
-6701000 USD
CY2013Q4 med Deferred Tax Liability Accrued Expenses And Deferred Costs
DeferredTaxLiabilityAccruedExpensesAndDeferredCosts
1260000 USD
CY2012Q4 med Deferred Tax Liability Accrued Expenses And Deferred Costs
DeferredTaxLiabilityAccruedExpensesAndDeferredCosts
690000 USD
CY2011Q4 med Deferred Tax Liability Accrued Expenses And Deferred Costs
DeferredTaxLiabilityAccruedExpensesAndDeferredCosts
516000 USD
CY2012 us-gaap Equipment Expense
EquipmentExpense
1926000 USD
CY2011 us-gaap Equipment Expense
EquipmentExpense
1929000 USD
CY2013 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
270000000 USD
CY2012Q3 med Payments To Civil Penalty
PaymentsToCivilPenalty
3700000 USD
CY2013 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 9pt"> Reclassification</font></strong> <font style="FONT-SIZE: 9pt"> &#150; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the consolidated financial statements had a material impact on the presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 9pt">Use of Estimates</font></strong> <font style="FONT-SIZE: 9pt">&#150; The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 9pt">Concentration of Credit Risk</font></strong> <font style="FONT-SIZE: 9pt">&#150; Our cash and cash equivalents and available-for-sale securities are maintained at several financial institutions, and the balances with these financial institutions often exceed the amount of insurance provided on such accounts by the Federal Deposit Insurance Corporation. The cash and cash equivalents generally are maintained with financial institutions with reputable credit, and therefore bear minimal credit risk. Historically, we have not experienced any losses due to such concentration of credit risk.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Revenue Recognition Leases Operating
RevenueRecognitionLeasesOperating
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 9pt">Operating Leases -</font></strong> <font style="FONT-SIZE: 9pt">Medifast leases retail stores, distribution facilities, and office space under operating leases. Many of our lease agreements contain tenant improvement allowances, rent holidays, rent escalation clauses, and contingent rent provisions. The Company recognizes incentives and minimum rental expenses on a straight-line basis over the terms of the leases. We commence recording rent expense on the date of initial possession, which is generally when we enter the space and begin to make improvements to properties for our intended use. For tenant improvement allowances and rent holidays, we record a deferred rent liability on the consolidated balance sheets and amortize the deferred rent over the terms of the leases as reductions to rent expense on the consolidated statements of income.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 9pt">For scheduled rent escalation clauses during the lease terms or for rental payments commencing at a date other than the date of initial occupancy, we record minimum rental expenses on a straight-line basis over the terms of the leases on the consolidated statements of income. Several leases provide for contingent rents, which are determined as a percentage of gross sales in excess of specified levels. We record a contingent rent liability on the consolidated balance sheets and the corresponding rent expense when we determine achieving the specified levels is probable.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
0 USD
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.009 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.028 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037 pure
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11965000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8559000 USD
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9688000 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
304000 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
679000 USD
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1015000 USD
CY2013 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
979000 USD
CY2012 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
902000 USD
CY2011 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
248000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1389000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0 USD
CY2013 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
-173000 USD
CY2012 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
190000 USD
CY2011 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
-71000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
-459000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
-267000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
-336000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
-707000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
-686000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Contingencies Other
IncomeTaxReconciliationTaxContingenciesOther
-1051000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
79000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.029 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.037 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.009 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.057 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.005 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.008 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.003 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.013 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.011 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.012 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Other
EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
-0.021 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Other
EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
-0.028 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Other
EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
-0.039 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
-0.002 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.299 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.351 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.330 pure
CY2013Q4 med Deferred Tax Asset Capital Loss Carry Forward Federal
DeferredTaxAssetCapitalLossCarryForwardFederal
79000 USD
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2200000 USD
CY2013 us-gaap Tax Credit Carryforward Expiration Date
TaxCreditCarryforwardExpirationDate
2017-12-31
CY2013 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1361000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 USD
CY2013Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
1131000 USD
CY2013 us-gaap Severance Costs1
SeveranceCosts1
80000 USD
CY2013 med Net Lease Liability
NetLeaseLiability
1131000 USD
CY2013 med Fixed Asset Disposals
FixedAssetDisposals
771000 USD
CY2013 med Other Closure Expenses
OtherClosureExpenses
148000 USD
CY2013 us-gaap Other Expenses
OtherExpenses
2130000 USD
CY2013 us-gaap Sales Returns And Allowances Goods
SalesReturnsAndAllowancesGoods
525000 USD
CY2012 us-gaap Sales Returns And Allowances Goods
SalesReturnsAndAllowancesGoods
300000 USD
CY2013 med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
43610 shares
CY2012 med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
17827 shares
CY2011 med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
233477 shares
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
71956000 USD
CY2013 med Capital Loss Carryforward Term
CapitalLossCarryforwardTerm
P5Y
CY2013 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR rate plus 1.75%, which was 1.92%
CY2013 med Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2027
CY2013 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
74000 USD
CY2012 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-2000 USD
CY2011 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-207000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
122000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
242000 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
24000000 USD
CY2012 us-gaap Advertising Expense
AdvertisingExpense
31000000 USD
CY2011 us-gaap Advertising Expense
AdvertisingExpense
27000000 USD
CY2013 med Clinic Closure Costs
ClinicClosureCosts
2100000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1300000 USD
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2013Q4 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
63750 shares

Files In Submission

Name View Source Status
0001144204-14-016118-index-headers.html Edgar Link pending
0001144204-14-016118-index.html Edgar Link pending
0001144204-14-016118.txt Edgar Link pending
0001144204-14-016118-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ft0001img-1.jpg Edgar Link pending
med-20131231.xml Edgar Link completed
med-20131231.xsd Edgar Link pending
med-20131231_cal.xml Edgar Link unprocessable
med-20131231_def.xml Edgar Link unprocessable
med-20131231_lab.xml Edgar Link unprocessable
med-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v370288_10k.htm Edgar Link pending
v370288_ex21-1.htm Edgar Link pending
v370288_ex23-1.htm Edgar Link pending
v370288_ex31-1.htm Edgar Link pending
v370288_ex31-2.htm Edgar Link pending
v370288_ex32.htm Edgar Link pending